ReleaseWire

Ace Therapeutics Accelerates Preclinical Psychiatry Research by Rolling out Customized Animal Models

Fri, 04 Apr 2025 08:45:00 -0500

New York, NY -- (ReleaseWire) -- 04/04/2025 -- As a preclinical contract research provider dedicated to offering comprehensive research services, Ace Therapeutics provides a complete one-stop service for developing custom animal models to support preclinical psychiatry research. The opportunity to apply such models towards revolutionizing research in mental health can allow for the discovery of novel therapies for these disorders.

Read the full press release at http://www.releasewire.com/press-releases/release-3.htm

Ace Therapeutics Releases Proteomic Analysis Services for Glaucoma Research

Thu, 30 May 2024 08:15:00 -0500

New York, NY -- (ReleaseWire) -- 05/30/2024 -- Ace Therapeutics, an integrated service provider for glaucoma research, is proud to announce the release of its proteomic analysis services for glaucoma research. These cutting-edge analysis services are expected to revolutionize the way researchers approach the study of glaucoma, a leading cause of irreversible blindness worldwide.

Read the full press release at http://www.releasewire.com/press-releases/release-3.htm

Ace Infectious Announces Antimicrobial Peptide Development Services to Drive Forward Drug Development Against Superbugs

Mon, 15 Apr 2024 13:35:00 -0500

New York, NY -- (ReleaseWire) -- 04/15/2024 -- Ace Infectious, a one-stop shop for researchers devoted to making advancements in infectious diseases including superbugs and H. pylori, is thrilled to announce the launch of its antimicrobial peptide development services. This ground-breaking service will revolutionize drug development efforts against the growing threat of superbugs, providing innovative solutions to combat infectious diseases.

Read the full press release at http://www.releasewire.com/press-releases/release-3.htm

Amerigo Scientific's GC Capillary Columns Enable Exceptional Analytical Performance

Mon, 15 Apr 2024 08:15:00 -0500

New York, NY -- (ReleaseWire) -- 04/15/2024 -- Amerigo Scientific, a distributor focused on providing critical products and services to biomedical and life science communities, is pleased to announce the launch of its new line of gas chromatography (GC) capillary columns. These columns offer unparalleled performance and reliability, making them an essential tool for laboratories looking to achieve precise and accurate analytical results.

Read the full press release at http://www.releasewire.com/press-releases/release-3.htm

Rdcthera Announces RDC Development and Analysis Services Based on Its Technology Platform

Wed, 17 Jan 2024 11:46:00 -0600

New York, NY -- (ReleaseWire) -- 01/17/2024 -- In a groundbreaking development for the field of drug discovery and diagnosis, Rdcthera, a professional CRO company offering efficient and customized R&D services related to radionuclide drug conjugates (RDCs), has announced the release of its RDC development and analysis services. Leveraging its cutting-edge technology platform, Rdcthera aims to empower drug developers with state-of-the-art tools for creating targeted radiopharmaceutical treatments.

Read the full press release at http://www.releasewire.com/press-releases/release-3.htm

To Fight Superbugs, Ace Infectious Unveils Phage Therapy Development Services

Wed, 27 Dec 2023 11:01:00 -0600

New York, NY -- (ReleaseWire) -- 12/27/2023 -- Ace Infectious announced today the launch of its phage therapy development services initiated with the aim of combating the global threat of superbugs. As a biotechnology company specializing in anti-superbug drug and therapy development, Ace Infectious is dedicated to providing innovative, effective, and safe development services to support scientific communities addressing the urgent need for alternative therapies to fight drug-resistant bacterial infections.

Read the full press release at http://www.releasewire.com/press-releases/release-3.htm

Ace Metabolism Advances Disease Research with Iron Metabolism Solutions

Wed, 13 Dec 2023 11:25:00 -0600

New York, NY -- (ReleaseWire) -- 12/13/2023 -- Ace Metabolism, a leading biotechnology company, is making great strides in disease research through their innovative iron metabolism-related disease research services. By unlocking the secrets of iron regulation within the body, Ace Metabolism is poised to transform the understanding and treatment of various iron metabolism-associated diseases.

Read the full press release at http://www.releasewire.com/press-releases/release-3.htm

Amerigo Scientific's New Lab Offering: S-Silver SERS Substrates

Wed, 06 Dec 2023 10:50:00 -0600

New York, NY -- (ReleaseWire) -- 12/06/2023 -- Amerigo Scientific, a distributor focused on providing critical products and services to biomedical and life science communities, announced the launch of its latest innovation in the field of surface-enhanced Raman spectroscopy (SERS) – S-Silver SERS substrates. With this exciting addition to its extensive product portfolio, Amerigo Scientific aims to empower researchers, scientists, and industry professionals with the most advanced tools for enhanced spectroscopic analysis.

Read the full press release at http://www.releasewire.com/press-releases/release-3.htm

Ace Neuroscience Launches Drug Development Services for Stroke and Psychiatric Disorders

Wed, 06 Dec 2023 10:50:00 -0600

New York, NY -- (ReleaseWire) -- 12/06/2023 -- Ace Neuroscience, a preclinical CRO service provider engaged in the research of stroke and antipsychotic drug development, has announced the launch of its drug development services for stroke and psychiatric disorders. The company aims to leverage its expertise and cutting-edge technology to develop innovative treatments for these conditions.

Read the full press release at http://www.releasewire.com/press-releases/release-3.htm

Amerigo Scientific Unveils CRISPR/Cas Enzymes to Expand the CRISPR Toolbox

Thu, 12 Oct 2023 11:00:00 -0500

New York, NY -- (ReleaseWire) -- 10/12/2023 -- Amerigo Scientific, as a distributor focused on providing critical products and services to biomedical and life science communities, announced the release of a groundbreaking selection of CRISPR/Cas enzymes to its extensive life science portfolio, aimed at further expanding the vast potential of the CRISPR toolbox. This addition brings cutting-edge genetic editing tools to scientists and researchers in a variety of fields.

Read the full press release at http://www.releasewire.com/press-releases/release-3.htm

NutriKane Set to Break Into the U.S. Market with a Range of Natural, Science-Backed Products Designed to Improve Health & Wellness

Thu, 07 Sep 2023 11:20:00 -0500

Boca Raton, FL -- (ReleaseWire) -- 09/07/2023 -- NutriKane, the pioneer in plant-based health products with over a decade of research and success, is excited to announce its upcoming launch in the United States.

Read the full press release at http://www.releasewire.com/press-releases/release-3.htm

Liver Medic Is Dedicated to Helping with the Negative Effects of Bad Gut Health

Thu, 02 Mar 2023 10:18:00 -0600

Coral Springs, FL -- (ReleaseWire) -- 03/02/2023 -- Liver Medic, focused on the most efficacious and cleanest ways to formulate products to maximize healing only nature can provide, has been working on helping as many people as possible correct their bad gut health. Getting off track with food choices isn't a big deal when it only happens once in a while, but realistically everyone could do better in this department. Fortunately, there are natural options that can help from Liver Medic.

Read the full press release at http://www.releasewire.com/press-releases/release-3.htm

Announcing Druglike – A Web3 Drug Discovery Platform

Wed, 12 Oct 2022 11:45:02 -0500

New York, NY -- (ReleaseWire) -- 07/25/2022 -- Druglike, a Web3 drug discovery software platform co-founded by Martin Shkreli, today released a demo, website, and whitepaper detailing its efforts to democratize the costs, access, and rewards of computational drug discovery.

Read the full press release at http://www.releasewire.com/press-releases/release-3.htm

Psoriasis Drugs Market Is Predicted to Progress at a CAGR of 6.5% to Reach a Valuation of US$ 21.48 Bn by 2031

Thu, 31 Mar 2022 11:59:04 -0500

New york, NY -- (ReleaseWire) -- 03/31/2022 -- A number of innovative and advanced therapies for the treatment and management of psoriasis are under development, many of which have novel targets and mechanisms of action.

Read the full press release at http://www.releasewire.com/press-releases/release-3.htm

Enzolytics IPF Immune Will Soon Be Available to American Consumers

Tue, 22 Feb 2022 12:10:03 -0600

Boca Raton, FL -- (ReleaseWire) -- 02/22/2022 -- Enzolytics IPF Immune™, an immune modulator, will be available later this year to American consumers, who, during the pandemic, have been seeking out immunity booster supplements to give themselves a health advantage.

Read the full press release at http://www.releasewire.com/press-releases/release-3.htm

Herboxa Developed the Purest and All Natural Formula for Lung Support

Wed, 12 Jan 2022 03:59:02 -0600

Düsseldorf, Germany -- (ReleaseWire) -- 01/12/2022 -- Staying healthy is a task that is performed by the combination of the kind of lifestyle we live, the kind of food we eat and how we help boost our system with the supplements we take to make our body system (both internal and external) stronger.

Read the full press release at http://www.releasewire.com/press-releases/release-3.htm

Compounding Pharmacy, ABC Compounding Pharmacy Launches New Resource Page for Patients

Wed, 24 Nov 2021 11:10:03 -0600

Encino, CA -- (ReleaseWire) -- 11/24/2021 -- Compounding Pharmacy ABC Compounding Pharmacy Launches New Resource Page for Patients. ABC Compounding Pharmacy is a world-renowned compound medicine pharmacy led by a team of trusted and reliable pharmacists, technicians, and chemists with extensive experience in the industry. Over the years, ABC Compounding Pharmacy has established itself as the go-to compounding pharmacy specializing in a myriad of medications.

Read the full press release at http://www.releasewire.com/press-releases/release-3.htm

Newly Launched Podcast Offers Medical Professionals an Intriguing Blend of Science, Tales from the Trenches, & Free CME

Wed, 30 Jun 2021 13:14:00 -0500

Springfield, MO -- (ReleaseWire) -- 06/30/2021 -- The search for an interesting and edifying medical podcast is over. The On Medical Grounds Podcast is available now at OnMedicalGrounds.com, Apple Podcasts, Spotify, Google Podcasts, and other major podcast platforms.

Read the full press release at http://www.releasewire.com/press-releases/release-3.htm

Outcomes and Risk Factors Associated with COVID-19 and Multiple Sclerosis Published in JAMA Neurology

Mon, 22 Mar 2021 09:15:00 -0500

Hackensack, NJ -- (ReleaseWire) -- 03/22/2021 -- An original investigation of the outcomes and risk factors associated with COVID-19 from a cross-section of multiple sclerosis patients from the COViMS North American registry was published online on March 19th in JAMA Neurology.

Read the full press release at http://www.releasewire.com/press-releases/release-3.htm

Frontida BioPharm, Inc. Launches CAT.one Testing to Support Abuse-Deterrent Product Development

Wed, 13 Jan 2021 08:00:00 -0600

Philadelphia, PA -- (ReleaseWire) -- 01/13/2021 -- Frontida BioPharm, Inc., a pharmaceutical Contract Development and Manufacturing Organization based in Philadelphia and Chicago areas, announced today the launch of its new Category 1 (CAT.ONETM) in vitro testing and evaluation services to support development and regulatory approvals for abuse-deterrent formulations of pain management and Central Nervous System (CNS) targeted therapies.

Read the full press release at http://www.releasewire.com/press-releases/release-3.htm

When Treating Chronic Prostatitis, by Contrast with Antibiotics, Herbal Medicine Diuretic and Anti-Inflammatory Pill Is More Favored

Fri, 11 Dec 2020 10:44:00 -0600

Los Angeles, CA -- (ReleaseWire) -- 12/11/2020 -- Commonly, antibiotics can induce drug resistance, especially in the treatment of chronic diseases. Long-term use of antibiotics is more likely to induce the emergence of drug-resistant microbes. The same is true of chronic prostatitis. While the herbal medicine Diuretic and Anti-inflammatory Pill can avoid this problem well, and it can effectively kill bacteria and eliminate inflammation, which has been favored by many patients with chronic prostatitis.

Read the full press release at http://www.releasewire.com/press-releases/release-3.htm

Frontida BioPharm, Inc. has Been Recognized as a Minority Owned Contract Development and Manufacturing Organization

Thu, 10 Dec 2020 09:55:00 -0600

Philadelphia, PA -- (ReleaseWire) -- 12/10/2020 -- Frontida BioPharm, Inc., a pharmaceutical Contract Development and Manufacturing Organization based in Philadelphia and Chicago areas, has been granted full certifiable recognition by The Eastern Minority Supplier Development Council as a Minority-Owned Business Enterprise (certified MBE).

Read the full press release at http://www.releasewire.com/press-releases/release-3.htm

Frontida BioPharm, Inc. Announces Puneet Sapra as New Chief Financial Officer

Wed, 02 Dec 2020 12:35:00 -0600

Philadelphia, PA -- (ReleaseWire) -- 12/02/2020 -- Frontida BioPharm, Inc., a pharmaceutical Contract Development and Manufacturing Organization based in Philadelphia and Chicago areas, announced today the appointment of Puneet Sapra as new Chief Financial Officer. Mr. Sapra will be replacing Andrew Wang, who recently accepted the CFO role at Frontage Holdings Corporation, a Contract Research Organization based in the USA and China (HK 1521).

Read the full press release at http://www.releasewire.com/press-releases/release-3.htm

Pacemaker Procedures Globally Will Reach 2 Million by 2025

Mon, 30 Nov 2020 08:00:00 -0600

Vancouver, BC -- (ReleaseWire) -- 11/30/2020 -- Recent study projects millions of patients having pacemaker surgery by 2025 as new technologies and improvements lead to a higher number of devices implanted.

Read the full press release at http://www.releasewire.com/press-releases/release-3.htm

Frontida BioPharm, Inc. Announces Praful Agrawala, Ph.D., as Executive Vice President, Technology

Thu, 19 Nov 2020 09:51:00 -0600

Philadelphia, PA -- (ReleaseWire) -- 11/19/2020 -- Frontida BioPharm, Inc., a pharmaceutical Contract Development and Manufacturing Organization based in Philadelphia and Chicago areas, announced today the appointment of Praful Agrawala, Ph.D., as Executive Vice President, Technology. Dr. Agrawala adds years of pharmaceutical product development leadership experience to Frontida after serving in executive roles at Amneal Pharmaceuticals, Sanofi-Aventis, and Schering-Plough Research Institute.

Read the full press release at http://www.releasewire.com/press-releases/release-3.htm